Venipuncture is performed in nearly every hospital department, specialty clinic and physician’s office and is one of the first procedures performed. The success of the IV start or blood draw can result in a domino effect which impacts the rest of the patient’s stay.
VeinViewer® has been embraced by clinicians in over 40 countries around the world as a true solution to improving peripheral vascular access. Clinically proven to reduce the number of attempts and time to start an IV as well as significantly improve patient satisfaction, VeinViewer not only has the potential to positively affect patient outcomes but also your bottom line.
VeinViewer Vision
Bottom Line Benefits:
- Reduce the total cost of IV placements
- According to one study, VeinViewer has the potential to save a hospital starting 1,000 IV’s per month over $80,000 a year.
- Improve efficiency by reducing IV start times.
- Avoid treatment delays.
- Allocate staff time more effectively.
- Avoid unnecessary higher acuity procedures and the associated complications
- PICC lines and CVC’s are significantly more expensive than a peripheral IV and expose patients to a higher risk for blood stream infections.
- Treatment of a catheter-related blood stream infection (CRBSI) averages between $30,000 and $70,000 to treat.
- Centers for Medicare and Medicaid no longer reimburse for the treatment of a CRBSI, and many major insurers have followed suit.
- Improve patient satisfaction
- VeinViewer more than doubled patient satisfaction in one study.
- Market your efforts to improve patient care and increase patient traffic to your facility.
Contact Christie for a demonstration of this innovative technology.